145 related articles for article (PubMed ID: 3571433)
1. Increased spontaneous immunoglobulin secretion associated with cyclophosphamide-induced immune suppression.
Martínez-Maza O; Moody DJ; Rezai AR; Ellison GW; Myers LW; Tourtellotte WW; Fahey JL
J Clin Immunol; 1987 Mar; 7(2):107-13. PubMed ID: 3571433
[TBL] [Abstract][Full Text] [Related]
2. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.
Henriksson A; Kam-Hansen S; Link H
Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372
[TBL] [Abstract][Full Text] [Related]
3. The effect of cyclophosphamide on B cells and 'background' immunoglobulin-secreting cells in mice.
Sabbele NR; Van Oudenaren A; Benner R
Immunopharmacology; 1988; 15(1):21-30. PubMed ID: 3258856
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous antibody-secreting human blood lymphocytes detected with a protein A plaque assay.
Kunori T; Broman P; Tan M
Clin Exp Immunol; 1980 Oct; 42(1):162-6. PubMed ID: 7006874
[TBL] [Abstract][Full Text] [Related]
5. Suppression of polyclonal human B cell activation by IgG binding factors: interference with the maturation of Ig-containing cells into Ig-secreting cells.
Bich-Thuy LT; Banchereau J; Revillard JP
Cell Immunol; 1984 Aug; 87(1):231-9. PubMed ID: 6204775
[TBL] [Abstract][Full Text] [Related]
6. Delayed in vitro immunoglobulin production by cord lymphocytes.
Miyagawa Y; Sugita K; Komiyama A; Akabane T
Pediatrics; 1980 Mar; 65(3):497-500. PubMed ID: 6965781
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs.
MacDermott RP; Beale MG; Alley CD; Nash GS; Bertovich MJ; Bragdon MJ
Ann N Y Acad Sci; 1983 Jun; 409():498-509. PubMed ID: 6575715
[TBL] [Abstract][Full Text] [Related]
8. Autoreactive lymphocytes in thyroid disorders. Quantitation of anti-thyroglobulin antibody formation by a specific haemolytic plaque forming cell (PFC) assay.
Petersen J; Feldt-Rasmussen U; Larsen F; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1986 Sep; 113(1):50-5. PubMed ID: 3532657
[TBL] [Abstract][Full Text] [Related]
9. In vitro immunoglobulin production by mononuclear cells in rheumatoid arthritis.
Panush RS; Katz P; Longley S
Clin Immunol Immunopathol; 1983 Aug; 28(2):252-64. PubMed ID: 6347489
[TBL] [Abstract][Full Text] [Related]
10. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
Saiki O; Ralph P
Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
[TBL] [Abstract][Full Text] [Related]
11. The effects of nitrogen mustards on the proliferative and Ig synthetic response of human peripheral blood lymphocytes.
Chien MM; Ashman RF
Immunopharmacology; 1986 Oct; 12(2):155-66. PubMed ID: 3771193
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte function in human bone marrow. III. Isotype commitment, metabolic and secretory characteristics of immunoglobulin producing cells.
Hibi T; Dosch HM
Cell Immunol; 1986 Mar; 98(1):34-45. PubMed ID: 3742617
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis.
Wajgt A; Górny M; Szczechowski L; Grzybowski G; Ochudło S
Acta Med Pol; 1989; 30(3-4):121-8. PubMed ID: 2485126
[TBL] [Abstract][Full Text] [Related]
14. Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
Shih WW; Baumhefner RW; Tourtellotte WW; Haskell CM; Korn EL; Fahey JL
Clin Exp Immunol; 1983 Jul; 53(1):122-32. PubMed ID: 6603303
[TBL] [Abstract][Full Text] [Related]
15. Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Moody DJ; Kagan J; Liao D; Ellison GW; Myers LW
J Neuroimmunol; 1987 Mar; 14(2):161-73. PubMed ID: 3818941
[TBL] [Abstract][Full Text] [Related]
16. Long term administration of cyclophosphamide into MRL/1 mice. II. The effects on the isotype of anti-DNA antibodies and immunoglobulin secreting cells in the spleen.
Shiraki M; Fujiwara M
Clin Exp Immunol; 1984 Mar; 55(3):519-24. PubMed ID: 6608425
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human B lymphocyte function by cyclophosphamide.
Cupps TR; Edgar LC; Fauci AS
J Immunol; 1982 Jun; 128(6):2453-7. PubMed ID: 6978904
[TBL] [Abstract][Full Text] [Related]
18. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Comabella M; Balashov K; Issazadeh S; Smith D; Weiner HL; Khoury SJ
J Clin Invest; 1998 Aug; 102(4):671-8. PubMed ID: 9710434
[TBL] [Abstract][Full Text] [Related]
19. Enumerating immunoglobulin-secreting cells among peripheral human lymphocytes. A hemolytic plaque assay for a B cell function.
Eby WC; Chong CA; Dray S; Molinaro GA
J Immunol; 1975 Dec; 115(6):1700-3. PubMed ID: 1102610
[TBL] [Abstract][Full Text] [Related]
20. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Smith DR; Balashov KE; Hafler DA; Khoury SJ; Weiner HL
Ann Neurol; 1997 Sep; 42(3):313-8. PubMed ID: 9307252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
